J, D., C, T., C, A., SA, A., A, B., R, B., . . . DL, F. (2025). Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy. NPJ vaccines, 10(1), 98. https://doi.org/10.1038/s41541-025-01151-8
Chicago Style (17th ed.) CitationJ, Davis-Porada, et al. "Durable T Cell Immunity to COVID-19 Vaccines in MS Patients on B Cell Depletion Therapy." NPJ Vaccines 10, no. 1 (2025): 98. https://doi.org/10.1038/s41541-025-01151-8.
MLA (9th ed.) CitationJ, Davis-Porada, et al. "Durable T Cell Immunity to COVID-19 Vaccines in MS Patients on B Cell Depletion Therapy." NPJ Vaccines, vol. 10, no. 1, 2025, p. 98, https://doi.org/10.1038/s41541-025-01151-8.
Warning: These citations may not always be 100% accurate.